Hepcludex

bulevirtide

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Hepcludex, covering 2022-10-28 to 2026-03-31. Get the full timeline:

Most recent: EMA Authorised: Hepcludex (bulevirtide acetate) — Gilead Sciences Ireland UC